For this study, we collected and analyzed the correlation between clinical data and levels of serum inflammatory cytokines (interleukin [IL]-2, IL-6, IL-8, and tumor necrosis factor [TNF]-α) to guide the prognosis of patients who suffered advanced-stage lung cancer. The gene discussed is IL6; the disease is lung carcinoma.